Glycopyrrolate Injection
Product Images NDC 75834-193

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 75834-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1ml-car.jpg (1ml Car)

Glycopyrrolate Injection, USP 0.2 mg/mL vial label for intramuscular and intravenous use. The label indicates it contains benzyl alcohol as a preservative and is not for use in newborns. Manufactured by Nivagen Pharmaceuticals, Inc., the package contains 25 single-dose vials of 1 mL each. Storage instructions specify 20°C to 25°C (68°F to 77°F).*

FDA Label Image

1ml-label.jpg (1ml Label)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL, a single-dose vial for intramuscular and intravenous use. The label states it contains benzyl alcohol preservative and provides manufacturer details: Nivagen Pharmaceuticals, Inc., Sacramento, CA, made in Taiwan. It includes the NDC number, barcode, and spaces for lot number and expiration date.*

FDA Label Image

20ml-car.jpg (20ml Car)

Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) by Nivagen Pharmaceuticals, Inc. The injectable solution contains benzyl alcohol and is for intramuscular and intravenous use. The package contains 10 multiple-dose vials of 20 mL each. The label notes the product is not for use in newborns and includes storage instructions and manufacturer contact information.*

FDA Label Image

20ml-label.jpg (20ml Label)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL (4 mg/20 mL) in a 20 mL multiple dose vial. The label states it is for intramuscular and intravenous use, contains benzyl alcohol, and warns it is not for use in newborns. Manufactured for Nivagen Pharmaceuticals, Inc., the label includes storage instructions and a toll-free contact number.*

FDA Label Image

2ml-car.jpg (2ml Car)

Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) single-dose vial label by Nivagen Pharmaceuticals, Inc. The label indicates it is for intramuscular and intravenous use, contains benzyl alcohol preservative, and is not for use in newborns. The package contains 25 vials of 2 mL each. Storage instructions are also provided.*

FDA Label Image

2ml-label.jpg (2ml Label)

Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (equivalent to 0.2 mg/mL) by Nivagen Pharmaceuticals, Inc. It is a 2 mL single dose vial for intramuscular and intravenous use containing glycopyrrolate with benzyl alcohol as a preservative. The label includes lot and expiration date fields, manufacturer details, and a barcode.*

FDA Label Image

5ml-car.jpg (5ml Car)

Label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) by Nivagen Pharmaceuticals, Inc. The label states it contains benzyl alcohol, is for intramuscular and intravenous use, and is not for use in newborns. It includes storage instructions, lot and expiration placeholders, and a barcode.*

FDA Label Image

5ml-label.jpg (5ml Label)

Label for Glycopyrrolate Injection, USP 1 mg/mL (0.2 mg/mL) by Nivagen Pharmaceuticals, Inc. This 5 mL multiple dose vial contains glycopyrrolate injection for intramuscular and intravenous use. The label includes storage instructions, a lot and expiration date section, a warning that it is not for use in newborns, and contact information for the manufacturer.*

FDA Label Image

Struc (Struc)

Chemical structure of glycopyrrolate showing its molecular formula (C19H28BrNO3) and molecular weight (398.33). The diagram includes the arrangement of atoms and bonds characteristic of glycopyrrolate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.